List view / Grid view
AstraZeneca announced that Simon Lowth, CFO and Executive Director, will…
15 July 2013 | By AstraZeneca
AstraZeneca announced that Simon Lowth, CFO and Executive Director, will leave the company at the end of October...
AstraZeneca has made an initial payment of approximately $3.2 billion…
9 August 2012 | By AstraZeneca
AstraZeneca has made an initial payment of approximately $3.2 billion to Amylin Pharmaceuticals...
Bristol-Myers Squibb to acquire Amylin...
30 June 2012 | By AstraZeneca
Bristol-Myers Squibb to acquire Amylin...
AstraZeneca announced that Chief Executive Officer and Board member, David…
26 April 2012 | By AstraZeneca
AstraZeneca announced that Chief Executive Officer and Board member, David Brennan has decided to retire...
MedImmune Ventures closes investment in Australian company, NeuProtect Pty Ltd...
28 November 2011 | By AstraZeneca
MedImmune Ventures closes investment in Australian company, NeuProtect Pty Ltd...
